Pfizer Stock Price

-0.02 (-0.04%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 19,932,504
Bid Price
Ask Price
News (4)
Day High 52.84


52 Week Range


Day Low 51.63
Company Name Stock Ticker Symbol Market Type
Pfizer Inc PFE NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -0.04% 51.76 19:59:20
Open Price Low Price High Price Close Price Prev Close
51.74 51.63 52.84 51.72 51.78
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
129,871 19,932,504 $ 51.93 $ 1,035,017,036 - 41.445 - 61.71
Last Trade Time Type Quantity Stock Price Currency
19:59:45 6 $ 51.76 USD


Draw Mode:

Pfizer Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 290.55B 5.61B 5.61B $ 81.29B $ 24.30B 3.84 9.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 1.56 3.18% 11/03/22 -176.89k 0.30%

more financials information »

Pfizer News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PFE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week50.5652.8449.1850.7319,731,9071.202.37%
1 Month47.0752.8446.3149.5419,272,6084.699.96%
3 Months46.0952.8441.44546.3220,675,0125.6712.3%
6 Months53.2753.9241.44547.8819,572,553-1.51-2.83%
1 Year51.5161.7141.44551.0826,061,8860.250.49%
3 Years38.1061.7127.8842.5429,754,54813.6635.85%
5 Years35.7961.7127.8841.6126,189,20915.9744.62%

Pfizer Description

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.